Summit Financial LLC Boosts Investment in Intuitive Surgical, Inc.

Summit Financial LLC has significantly increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 28.4% during the fourth quarter, according to their latest filing with the Securities and Exchange Commission (SEC). After acquiring an additional 1,865 shares, Summit Financial now owns a total of 8,427 shares of the medical equipment provider's stock. At the close of the most recent reporting period, the value of Summit Financial's holdings in Intuitive Surgical amounted to approximately $4,398,000.

In addition to Summit Financial, several other institutional investors and hedge funds have also adjusted their positions in Intuitive Surgical over the past quarter. Atala Financial Inc initiated a new position in the company valued at around $25,000. Similarly, Berbice Capital Management LLC and BankPlus Trust Department also bought new stakes worth about $26,000 and $28,000, respectively. Summit Securities Group LLC and Kohmann Bosshard Financial Services LLC added new positions during the same period, valued at roughly $30,000 and $31,000. Currently, institutional investors collectively own 83.64% of the company's stock.

Intuitive Surgical Stock Performance

As of Tuesday, NASDAQ ISRG opened at $495.27. The stock has experienced a 52-week range, with a low of $364.17 and a high of $616.00. It currently has a 50-day moving average price of $554.33 and a 200-day moving average price of $532.98. Intuitive Surgical holds a market cap of $176.40 billion and has a price-to-earnings ratio of 77.27, as well as a P/E/G ratio of 5.85 and a beta of 1.43.

Analyst Ratings and Recommendations

Intuitive Surgical has been the subject of various recent research reports. Bernstein Bank recently raised its target price for the shares from $655.00 to $700.00, advising investors to adopt an "overweight" position. Conversely, Robert W. Baird lowered their target from $707.00 to $600.00, maintaining an "outperform" rating. Erste Group Bank downgraded Intuitive Surgical from a "strong-buy" to a "hold" rating. Additionally, Raymond James increased their target from $560.00 to $688.00, while Citigroup raised theirs from $640.00 to $711.00, advising a "buy" stance. Currently, one analyst has a sell rating on the stock, five recommend holding, and fifteen suggest buying, leading to a consensus rating of "Moderate Buy" with an average target price of $611.86.

Insider Transactions at Intuitive Surgical

In recent insider trading news, CFO Jamie Samath sold 269 shares of the stock on February 10, with the sale amounting to $158,710 at an average price of $590.00 per share. Following this transaction, Samath now owns 3,282 shares of Intuitive Surgical, valued at approximately $1,936,380, reflecting a 7.58% decrease in ownership. Additionally, Director Amal M. Johnson sold 4,635 shares on January 28, resulting in a total value of $2,626,191. This trade represented a 27.41% decrease in Johnson's position. In the past 90 days, insiders have sold a total of 33,754 shares worth $17,691,621, with corporate insiders holding only 0.70% of the stock.

Company Overview

Intuitive Surgical, Inc. specializes in developing, manufacturing, and marketing products designed to enhance the quality and accessibility of minimally invasive medical care both domestically and internationally. The company is well-known for its da Vinci Surgical System, which facilitates complex surgeries through a minimally invasive approach, as well as the Ion endoluminal system that expands their offerings into diagnostic procedures, specifically allowing for minimally invasive lung biopsies.

investment, stocks, healthcare